Objective-To establish whether changes of lung transfer for carbon monoxide (TLCO) IgA nephropathy and Henoch-Schonlein purpura, and may be involved in the immune mechanisms leading to TLCO abnormalities observed in Henoch-Schonlein purpura. To test this hypothesis we measured TLCO in children with IgA nephropathy during both acute exacerbations and haematuria-free phases of the disease. The aim of the study was to establish whether changes of TLCO were related to the phase of IgA nephropathy.
In children, IgA nephropathy (Berger's disease) is limited to the kidney, while Henoch-Schonlein purpura has multiorgan involvement. There are pathophysiological similarities between the two conditions, and common immunological findings, so some investigators consider the two diseases to be one entity.1 2 We have recently reported cases of Henoch-Schonlein purpura with interstitial lung involvement proved by a fall in lung diffusion capacity for carbon monoxide (TLCO) in the early stages of the disease and the persistence of this abnormality in children with Henoch-Schonlein purpura nephritis.34 IgA immune complexes are present in both IgA nephropathy and Henoch-Schonlein purpura, and may be involved in the immune mechanisms leading to TLCO abnormalities observed in Henoch-Schonlein purpura. To test this hypothesis we measured TLCO in children with IgA nephropathy during both acute exacerbations and haematuria-free phases of the disease. The aim of the study was to establish whether changes of TLCO were related to the phase of IgA nephropathy.
Methods
Twelve patients (1 1 boys and one girl) aged 7-1 to 17 2 years (mean 12 years) were prospectively enrolled from January 1990 to June 1993. All had recurrent macroscopic haematuria and a diagnosis of IgA nephropathy made after percutaneous renal biopsy. None had urinary tract infection or malformation, and abdominal ultrasonography was normal in all cases. No patient had known chronic or acute lung disease, clinical or laboratory symptoms of systemic lupus erythematosus or a history of Henoch-Schonlein purpura.
We measured proteinuria and blood haemoglobin at the time of all TLCO measurements. A chest x ray was performed to rule out pneumonia. Respiratory tests included vital capacity and functional residual capacity (FRC) determined by helium dilution technique, blood gas measurements (Pao2 and Paco2) on arterialised capillary blood collected from the ear lobe, and TLCO. We measured TLCO by a previously described method.5 6 Briefly, under resting conditions during steady state, alveolar gas was sampled and carbon monoxide concentration measured. This method has been shown to be reliable, with less than a 5./o difference in two consecutive measurements.3 5 episode was found in patient 3, in whom a low value had been detected in the preceding year just after gross haematuria. Radiological signs of interstitial lung involvement were minor but generally related to the decrease of TLCO, without evidence of other pulmonary abnormality.
We considered TLCO or TLCO/FRC to be within the normal range in six of nine patients tested more than three months after an episode of gross haematuria: mean TLCO and TLCO/FRC were respectively 101 (25)% and 87 (22)% of predicted value (figure). In patients 1, 2, 3, 5, and 8, in whom low values were found when haematuria was present or recent (within one month of tests), TLCO or TLCO/FRC reached the normal range during the intervals between the haematuric episodes, even when proteinuria persisted. The magnitude of impairment of lung diffusion was not related to severity of the glomerular lesions associated with IgA deposits, to the level of serum IgA, or to the degree of proteinuria.
Additionally, two patients with isolated gross haematuria initially considered to have IgA nephropathy were finally diagnosed as Alport syndrome after renal biopsy (absence of IgA deposits, thin basement membrane nephropathy by electronic microscopy, and hearing loss). Pulmonary function tests were performed during an episode of gross haematuria. Their lung volumes, chest x ray, blood gases, and lung diffusion were normal: TLCO was respectively 101% and 106% of predicted values, and TLCO/FRC was 11 3% and 109%. 
Discussion
We recently reported impairment of TLCO in children with Henoch-Schonlein purpura, but this has not been described before in children with IgA nephropathy. Although we did not obtain paired acute and convalescent studies in eight patients, we found that TLCO was low in the early stages of Henoch-Schonlein purpura, became normal after disappearance of the clinical symptoms, and remained low when Henoch-Schonlein purpura nephritis persisted for months or years after the initial skin rash. Thus normal TLCO appeared to be associated with remission and it fell when HenochSchonlein purpura relapsed.3 4 In the present study, all patients with IgA nephropathy tested during or just after a bout of macroscopic haematuria had low values of TLCO. One TLCO was in the normal range one month after a haematuric episode. However, TLCO was low when measured in the same patient the year before, one month after gross haematuria.
Acute upper respiratory infections often precede clinical exacerbation of IgA nephropathy. Chronic pulmonary diseases have rarely been reported with IgA nephropathy, although pulmonary fibrosis, chronic asthma, and haemosiderosis have been described in adult patients.8 Children with interstitial lung disease, such as sarcoidosis, haemosiderosis, hypersensitivity pneumonitis, histiocytosis X, and malignancies with interstitial pneumonia, present with markedly abnormal chest x ray and decreased TLCO, with hypoxaemia and low lung volumes secondary to pulmonary fibrosis.7 Our results in IgA nephropathy show minimal radiological interstitial lesions. As in Henoch-Schonlein purpura, diffusion capacity measured by TLCO was the sole impaired pulmonary function.
IgA nephropathy and Henoch-Schonlein purpura have similar pathological findings, with mesangial IgA deposits.9 10 Overproduction of IgA, and circulating immune complexes containing IgA are seen in both diseases.2 [11] [12] [13] IgA deposits are also found in unaffected skin of patients with HenochSchonlein purpura or IgA nephropathy, showing that immune deposits may be found in apparently normal tissues in the two diseases. 14 Sera of patients with IgA nephropathy and Henoch-Schonlein purpura nephritis contain circulating antibodies that can bind to an antigen of mesangial cells in culture. These antibodies can be detected in the haematuric phase of IgA nephropathy or acute HenochSchonlein purpura and disappear after partial or complete remission.15 16 Thus impairment of TLCO in both diseases is possibly related to the deposition of IgA containing immune complexes or other antibodies on the vascular side of the alveolar-capillary membrane during the active phase. During periods of apparent clinical remission, TLCO is in the normal range in both diseases. This suggests it is in parallel with the disappearance of the immunological abnormalities observed in the acute phase.
Normalisation of TLCO, observed after the haematuric phase, was not related to the level of IgA, the severity or extent of glomerular changes, or the residual proteinuria in IgA nephropathy. Low TLCO therefore appears to be a result of disease activity where there is rash or haematuria, but may be normal between acute episodes of both diseases, even when there are sequelae of glomerular injury. There is a significant difference between the tests performed when haematuria is present and those performed more than three months after an episode of gross haematuria: p<00l (present v previous). We tested only two patients with Alport's syndrome, in whom the diffusion capacity performed during an episode of macroscopic haematuria was normal.
A low TLCO value, as in the acute phase of Henoch-Schonlein purpura, seems to be a major feature during episodes of macroscopic haematuria in IgA nephropathy. This noninvasive technique, easy to perform and repeat, could be of great help for the differential diagnosis of IgA nephropathy in children with haematuria. However, further studies are needed in children with haematuria from other glomerular diseases to demonstrate the specificity of the test. 
